Sargent Bickham Lagudis LLC Bluebird Bio, Inc. Transaction History

Sargent Bickham Lagudis LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$8.96 - $16.31 $896 - $1,630	-100 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$18.04 - $22.09 $1,804 - $2,209	100 New	100 $3,000
Q4 2020 May 24, 2021	SELL	$27.5 - $37.92 $3,107 - $4,284	-113 Closed	0 $0
Q2 2019 Sep 13, 2021	SELL	$75.84 - $105.21 $7,584 - $10,521	-100 Reduced 46.95%	113 $14,000
Q1 2019 Sep 13, 2021	BUY	$64.44 - $104.11 $6,444 - $10,411	100 Added 88.5%	213 $34,000
Q1 2016 Sep 07, 2021	BUY	N/A	113	113 $5,000

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $601M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.